• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

9
6
4
4
2

COUNTRY

2
1
1
1

CATEGORIES

  • 11
  • 5
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1

PRICE

0
4
4
18

PUBLISHED

0
0
1
18

PRODUCT TYPE

18

Search "Pricing and Reimbursement Risk and Opportunities in Pharmaceutical Deal Making" returned 18 results.

PRODUCT TITLE
Pricing and Reimbursement Strategies for Diagnostics: Overcoming Reimbursement Issues and Navigating the Regulatory Environment Pricing and Reimbursement Strategies for Diagnostics: Overcoming Reimbursement Issues and Navigating the Regulatory Environment - Product Thumbnail Image

Pricing and Reimbursement Strategies for Diagnostics: Overcoming Reimbursement Issues and Navigating the Regulatory Environment

The reimbursement for diagnostics is the key requirement for both the diagnostic providers and the payers because while 5-7% of the hospital cost is incurred on diagnostics, they are used for around...

June 2010
FROM
Pharmaceuticals - Global Outlook Pharmaceuticals - Global Outlook - Product Thumbnail Image

Pharmaceuticals - Global Outlook

The global outlook series on Pharmaceuticals provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings Punctuated with 46 statistically rich tables, the...

January 2012
FROM

Pharmaceutical Research and Development (R&D) - Increasing Efficiency through Information Technology and Externalization

“Pharmaceutical Research and Development (R&D) - Increasing Efficency Through Information Technology and Externalization” provides key data, information and analysis on major pharmaceutical R&D practices...

May 2010
FROM
Drug Approval Process in Europe - An Outlook Drug Approval Process in Europe - An Outlook - Product Thumbnail Image

Drug Approval Process in Europe - An Outlook

This research deals with the drug approval process in Europe by focussing on the various marketing authorisation procedures, price controls and parallel trading A snapshot of the biosimilars approval...

December 2008
FROM

The Future of Contract Research Outsourcing - Market Forecasts to 2015, Geographical Landscape and Competitive Benchmarking

GBI Research, the leading business intelligence provider, has released its latest research, “The Future of Contract Research Outsourcing - Market Forecasts to 2015, Geographical Landscape and Competitive...

December 2009
FROM

Poland Pharmaceuticals and Healthcare Report Q2 2010

Business Monitor International's Poland Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments...

February 2010
Biomarkers and Related Tests for Molecular Diagnostics and Pharma/ Biotech R&D -- Companies Products and WW Market, 2004-2009 Biomarkers and Related Tests for Molecular Diagnostics and Pharma/ Biotech R&D -- Companies Products and WW Market, 2004-2009 - Product Thumbnail Image

Biomarkers and Related Tests for Molecular Diagnostics and Pharma/ Biotech R&D -- Companies Products and WW Market, 2004-2009

One of the big ideas that emerged since the completion of the human genome project involves new biomarkers and tests used for tailoring new drugs that match an individual’s genetic makeup This report...

July 2005
FROM

Companion Diagnostics in Personalized Medicine and Cancer Therapy

Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy This linkage could be important in the therapeutic...

June 2014
FROM

EpiCast Report: Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2022

EpiCast Report: Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2022 Idiopathic pulmonary fibrosis (IPF) is a chronic, fibrosing interstitial pneumonia of unknown cause that occurs primarily...

April 2013
FROM

Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020

Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020 Summary GlobalData, the industry analysis specialist, has released its new report, “Ovarian Cancer Therapeutics - Global...

February 2012
FROM

Gastric Cancer - Germany Drug Forecasts and Treatment Analysis to 2020

Gastric Cancer - Germany Drug Forecasts and Treatment Analysis to 2020 Summary Global Data, the industry analysis specialist, has released its new report, “Gastric Cancer - Germany Drug Forecasts...

April 2011
FROM

Poland Pharmaceuticals and Healthcare Report Q1 2009

Poland Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Poland's pharmaceuticals and healthcare industry Poland’s pharmaceutical market remains heavily...

February 2009
Emerging Markets Collection Emerging Markets Collection - Product Thumbnail Image

Emerging Markets Collection

Dossier Report Collections The authors are pleased to showcase Report Collections, focused on areas of critical importance to Pharma's success, present and future These Collections deliver expert views,...

November 2013
FROM
Generics/Biosimilars Collection Generics/Biosimilars Collection - Product Thumbnail Image

Generics/Biosimilars Collection

Dossier Report Collections The authors are pleased to showcase Report Collections, focused on areas of critical importance to Pharma's success, present and future These Collections deliver expert views,...

November 2013
FROM
Marketing Collection Marketing Collection - Product Thumbnail Image

Marketing Collection

Dossier Report Collections The authors are pleased to showcase Report Collections, focused on areas of critical importance to Pharma's success, present and future These Collections deliver expert views,...

November 2013
FROM

Testing Services Markets, SNP Analysis, DNA Sequencing, Retail Clinics, Companion Diagnostics

A perfect supplemental information resource for customers who have already purchased The Worldwide Market for In Vitro Diagnostic Tests, 6th Edition, The IVD Market Research Supplement bundle studies...

August 2008
FROM

Executive Report on Strategies in Switzerland

How to Strategically Evaluate Switzerland Perhaps the most efficient way of evaluating Switzerland is to consider key dimensions which themselves are composites of multiple factors. Composite portfolio...

June 2007

Executive Report on Strategies in Spain

How to Strategically Evaluate Spain Perhaps the most efficient way of evaluating Spain is to consider key dimensions which themselves are composites of multiple factors. Composite portfolio approaches...

June 2007
Loading Indicator

Our Clients

Our clients' logos